Naser‐Aldin Lashgari

574 total citations
30 papers, 405 citations indexed

About

Naser‐Aldin Lashgari is a scholar working on Molecular Biology, Surgery and Infectious Diseases. According to data from OpenAlex, Naser‐Aldin Lashgari has authored 30 papers receiving a total of 405 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Surgery and 4 papers in Infectious Diseases. Recurrent topics in Naser‐Aldin Lashgari's work include Helicobacter pylori-related gastroenterology studies (4 papers), Ginger and Zingiberaceae research (3 papers) and Gastrointestinal motility and disorders (2 papers). Naser‐Aldin Lashgari is often cited by papers focused on Helicobacter pylori-related gastroenterology studies (4 papers), Ginger and Zingiberaceae research (3 papers) and Gastrointestinal motility and disorders (2 papers). Naser‐Aldin Lashgari collaborates with scholars based in Iran, Australia and United States. Naser‐Aldin Lashgari's co-authors include Amir Hossein Abdolghaffari, Nazanin Momeni Roudsari, Saeideh Momtaz, Amirhossein Sahebkar, Maryam Shayan, Mohammad Ali Nilforoushzadeh, Sona Zare, Mohammad Hosein Farzaei, Basil D. Roufogalis and Anusha Bishayee and has published in prestigious journals such as Journal of Ethnopharmacology, Life Sciences and Journal of Cellular Physiology.

In The Last Decade

Naser‐Aldin Lashgari

27 papers receiving 396 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Naser‐Aldin Lashgari Iran 13 133 63 43 42 38 30 405
Nazanin Momeni Roudsari Iran 13 144 1.1× 69 1.1× 47 1.1× 39 0.9× 42 1.1× 27 431
Abdullah Alattar Saudi Arabia 15 235 1.8× 46 0.7× 41 1.0× 36 0.9× 33 0.9× 36 513
Yongsong Xu China 12 168 1.3× 67 1.1× 22 0.5× 41 1.0× 32 0.8× 31 405
Shuguang Yan China 13 252 1.9× 74 1.2× 71 1.7× 37 0.9× 19 0.5× 34 463
Xinyu Bai China 14 231 1.7× 44 0.7× 62 1.4× 37 0.9× 50 1.3× 47 538
Mohamed A. Shaheen Egypt 15 265 2.0× 57 0.9× 28 0.7× 32 0.8× 57 1.5× 41 623
Eman Mohamad El Nashar Egypt 13 119 0.9× 41 0.7× 28 0.7× 31 0.7× 46 1.2× 51 418
Yuke Li China 11 181 1.4× 62 1.0× 35 0.8× 43 1.0× 29 0.8× 23 478

Countries citing papers authored by Naser‐Aldin Lashgari

Since Specialization
Citations

This map shows the geographic impact of Naser‐Aldin Lashgari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naser‐Aldin Lashgari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naser‐Aldin Lashgari more than expected).

Fields of papers citing papers by Naser‐Aldin Lashgari

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Naser‐Aldin Lashgari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naser‐Aldin Lashgari. The network helps show where Naser‐Aldin Lashgari may publish in the future.

Co-authorship network of co-authors of Naser‐Aldin Lashgari

This figure shows the co-authorship network connecting the top 25 collaborators of Naser‐Aldin Lashgari. A scholar is included among the top collaborators of Naser‐Aldin Lashgari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naser‐Aldin Lashgari. Naser‐Aldin Lashgari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Szmit, Sebastian, et al.. (2025). Statins: Novel Approaches for the Management of Doxorubicin-Induced Cardiotoxicity—A Literature Review. Cardiovascular Toxicology. 25(9). 1429–1452. 1 indexed citations
2.
Lashgari, Naser‐Aldin, et al.. (2025). Psychedelics in the Treatment of Neurologic and Psychiatric Disorders: Coincidence or a New Point of View. Molecular Neurobiology. 62(11). 15070–15092. 1 indexed citations
3.
Lashgari, Naser‐Aldin, Nazanin Momeni Roudsari, Maryam Shayan, et al.. (2024). LRRK2; Communicative Role in the Treatment of Parkinson’s Diseaseand Ulcerative Colitis Overlapping. CNS & Neurological Disorders - Drug Targets. 23(10). 1177–1188. 1 indexed citations
4.
5.
Lashgari, Naser‐Aldin, Nazanin Momeni Roudsari, Saeideh Momtaz, et al.. (2024). Systematic Review on Herbal Preparations for Controlling VisceralHypersensitivity in Functional Gastrointestinal Disorders. Current Pharmaceutical Biotechnology. 25(13). 1632–1650. 2 indexed citations
6.
Gholami, Maryam, et al.. (2023). Evaluation of acute and sub-chronic oral toxicities of Neoneaster in rats. Journal of Ethnopharmacology. 311. 116388–116388. 2 indexed citations
7.
Lashgari, Naser‐Aldin, et al.. (2023). TLR/mTOR inflammatory signaling pathway: novel insight for the treatment of schizophrenia. Canadian Journal of Physiology and Pharmacology. 102(3). 150–160. 9 indexed citations
8.
Lashgari, Naser‐Aldin, et al.. (2023). Juglone Mediates Inflammatory Bowel Disease Through Inhibition ofTLR-4/NF KappaB Pathway in Acetic Acid-induced Colitis in Rats. Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry. 22(2). 92–103. 3 indexed citations
9.
Lashgari, Naser‐Aldin, Nazanin Momeni Roudsari, Maryam Shayan, et al.. (2023). Statins: Beneficial Effects in Treatment of COVID-19. Advances in experimental medicine and biology. 1412. 457–476.
10.
Momtaz, Saeideh, Maryam Baeeri, Danial Khayatan, et al.. (2023). Licofelone Attenuates Acetic Acid-Induced Colitis in Rats Through Suppression of the Inflammatory Mediators. Inflammation. 46(5). 1709–1724. 5 indexed citations
11.
Lashgari, Naser‐Aldin, et al.. (2023). IDO/Kynurenine; novel insight for treatment of inflammatory diseases. Cytokine. 166. 156206–156206. 23 indexed citations
12.
Lashgari, Naser‐Aldin, Nazanin Momeni Roudsari, Seyed Saeed Tamehri Zadeh, et al.. (2022). Statins block mammalian target of rapamycin pathway: a possible novel therapeutic strategy for inflammatory, malignant and neurodegenerative diseases. Inflammopharmacology. 31(1). 57–75. 16 indexed citations
13.
Roudsari, Nazanin Momeni, Naser‐Aldin Lashgari, Saeideh Momtaz, et al.. (2021). Inhibitors of the PI3K/Akt/mTOR Pathway in Prostate Cancer Chemoprevention and Intervention. Pharmaceutics. 13(8). 1195–1195. 49 indexed citations
14.
Roudsari, Nazanin Momeni, Naser‐Aldin Lashgari, Saeideh Momtaz, et al.. (2021). Ginger: A complementary approach for management of cardiovascular diseases. BioFactors. 47(6). 933–951. 24 indexed citations
15.
Lashgari, Naser‐Aldin, Nazanin Momeni Roudsari, Saeideh Momtaz, & Amir Hossein Abdolghaffari. (2021). Transmembrane serine protease 2 and angiotensin-converting enzyme 2 anti-inflammatory receptors for COVID-19/inflammatory bowel diseases treatment. World Journal of Gastroenterology. 27(46). 7943–7955. 1 indexed citations
16.
Lashgari, Naser‐Aldin, Nazanin Momeni Roudsari, Saeideh Momtaz, et al.. (2021). Current overview of opioids in progression of inflammatory bowel disease; pharmacological and clinical considerations. Molecular Biology Reports. 48(1). 855–874. 12 indexed citations
17.
Lashgari, Naser‐Aldin, Nazanin Momeni Roudsari, Saeideh Momtaz, et al.. (2020). Targeting Mammalian Target of Rapamycin: Prospects for the Treatment of Inflammatory Bowel Diseases. Current Medicinal Chemistry. 28(8). 1605–1624. 28 indexed citations
18.
Roudsari, Nazanin Momeni, et al.. (2020). PPARγ: A turning point for irritable bowel syndrome treatment. Life Sciences. 257. 118103–118103. 14 indexed citations
19.
Roudsari, Nazanin Momeni, Naser‐Aldin Lashgari, Saeideh Momtaz, et al.. (2019). Natural polyphenols for the prevention of irritable bowel syndrome: molecular mechanisms and targets; a comprehensive review. DARU Journal of Pharmaceutical Sciences. 27(2). 755–780. 31 indexed citations
20.
Lashgari, Naser‐Aldin, Amir Hossein Abdolghaffari, Yunes Panahi, et al.. (2018). Curcumin as a therapeutic candidate for multiple sclerosis: Molecular mechanisms and targets. Journal of Cellular Physiology. 234(8). 12237–12248. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nazanin Momeni Roudsari Breakdown of academic impact, for papers by Abdullah Alattar Breakdown of academic impact, for papers by Yongsong Xu Breakdown of academic impact, for papers by Shuguang Yan Breakdown of academic impact, for papers by Xinyu Bai Breakdown of academic impact, for papers by Mohamed A. Shaheen Breakdown of academic impact, for papers by Eman Mohamad El Nashar Breakdown of academic impact, for papers by Yuke Li
Rankless by CCL
2026